Medical Tidbits,St. Jude Medical Center Honored with the Prestigious Magnet® Recognition

biotech jobs, medical job, career advice

/PRNewswire/ — St. Jude Medical Center (SJMC) has earned Magnet recognition, a coveted national honor earned by only 8 percent of U.S. hospitals. This award is the highest accolade in nursing excellence that any hospital can receive.

The honor recognizes healthcare organizations that deliver an extraordinary level of patient care, demonstrate excellence in nursing practice, exceed national standards and benchmarks, and display innovation and leadership in improving outcomes.  read more

Tennessee Health Management Selects Medline as Exclusive Distribution Partner in $4 Million Prime Vendor Deal

MUNDELEIN, Ill.–(BUSINESS WIRE)–Medical supplier Medline and Tennessee Health Management today announced that Medline has been selected as the exclusive distribution partner of the health system’s 50-plus entities in a $4 million deal. read more

Teikoku Pharma USA, Inc. Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula

SAN JOSE, Calif /PRNewswire/ — Teikoku Pharma USA, Inc. (“Teikoku” or “the Company”) announced today that the U.S. Food and Drug Administration (“FDA”) has approved Docetaxel Injection, Non-Alcohol Formula (“Docetaxel Injection”) for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.  Teikoku entered into an exclusive licensing agreement with Eagle Pharmaceuticals Inc. (“Eagle Pharmaceuticals”)  in October 2015 to market, sell and distribute Docetaxel Injection in the U.S. read more

Sanofi Submits New Drug Application for the Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide

– Sanofi announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes. read more

2015 Aesculapius Award Recipients Announced

The recipient of the 2015 Aesculapius Award of Excellence for health related websites is:

COPD Foundation
www.COPD360social.org

A panel of judges, representing the health care, web publishing, and multimedia fields, evaluated entries. The annual award is named for the ancient Greek god of healing, Aesculapius. This award was established by the Health Improvement Institute, a non-profit, tax-exempt organization based in Bethesda, Maryland, to promote informed consumer lifestyle choices and health care decisions. read more

NDS wins 2015 Excellence in Surgical Products Award

/PRNewswire/ — NDS Surgical Imaging (NDS) has received high honors at the 2015 Excellence in Surgical Products (ESP) Awards. NDS was recognized for the fourth straight year, winning in the OR Visualization Category following the launch of its highly anticipated Radiance® Ultra 27″ endoscopy visualization platform. read more

ULURU Inc. Announces – AGREEMENT WITH ALTRAZEAL TRADING GmbH; EXPANSION OF ALTRAZEAL® DISTRIBUTION NETWORK; and UPDATE ON RECENT PRODUCT SHIPMENTS.

AGREEMENT WITH ALTRAZEAL TRADING GmbH

On May 14, 2015, ULURU Inc. (the “Company”) announced it would be acquiring the 75% ownership of Altrazeal Trading GmbH (“Altrazeal Trading”) not already owned by the Company (the “AT Acquisition”).  Altrazeal Trading held the rights to distribute the Company’s patented Altrazeal® wound dressing in the Designated Territories listed below. As previously disclosed, the completion of the AT Acquisition was delayed due to certain due-diligence activities and other matters. read more

Mylan Launches Generic Zyvox® Tablets

HERTFORDSHIRE, England and PITTSBURGH, Dec. 29, 2015 /PRNewswire/ — Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Linezolid Tablets, 600 mg, which is the generic version of Pfizer’s Zyvox® Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated in adults and children for the treatment of certain infections caused by susceptible Gram-positive bacteria.read more

Med Career News Medical Tidbits

Subscribe today for leading medical news and career advice from top medical recruiters!

Get Med Career News in your Inbox!

If you want to keep up with the latest news and career tips in the Medical Field subscribe today!

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.